Concepedia

Single-inhaler Therapy

Single-Inhaler Therapy is a combination inhaler formulation strategy belonging to the class of respiratory treatment modalities that integrates multiple pharmacologic agents into a single inhaler device to improve adherence and ensure coordinated delivery of therapy for chronic obstructive pulmonary disease or asthma.

141

Publications

9.4K

Citations

643

Authors

335

Institutions

Publications per year

2017–2026

61

Variants

Single-inhaler Combination Therapy

Parents

Publications

141

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

, , +17

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

W Szafrański, Alberto Cukier, Ana Sofia Ramírez et al. · European Respiratory Journal · 2003 · 889 citations · Full text

, , +17

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 442 citations · Full text

, , +17

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, Alberto Papi, Massimo Corradi et al. · The Lancet · 2016 · 424 citations · Full text

, , +17

Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma

Alberto Papi, Giorgio Walter Canonica, Piero Maestrelli et al. · New England Journal of Medicine · 2007 · 368 citations · Full text

, , +17

1–5 of 141

Authors

643

  1. AI
    Afisi Ismaila

    McMaster University, Canada

    12 publications · 355 citations

    12

    h-index

  2. AP
    Alberto Papi

    University of Ferrara, Italy

    11 publications · 1.8K citations

    11

    h-index

  3. DH
    David Halpin

    University of Exeter, United Kingdom

    10 publications · 1.5K citations

    10

    h-index

  4. DS
    Dave Singh

    University of Manchester, United Kingdom

    10 publications · 2.5K citations

    10

    h-index

  5. DA
    David A. Lipson

    University of Pennsylvania, United States

    9 publications · 1.5K citations

    9

    h-index

1–5 of 643

Institutions

335

  1. GlaxoSmithKline (United States)

    Philadelphia, United States

    18 h-index

    45 publications

    5.1K citations

  2. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    14 h-index

    57 publications

    23.7K citations

  3. McMaster University

    Hamilton, Canada

    13 h-index

    13 publications

    471 citations

  4. Research Triangle Park Foundation

    Durham, United States

    13 h-index

    22 publications

    3.7K citations

  5. AstraZeneca (Sweden)

    Södertälje, Sweden

    12 h-index

    25 publications

    4.2K citations

  6. Impact

    Ottawa, Canada

    11 h-index

    10 publications

    326 citations

  7. Chiesi (Italy)

    Parma, Italy

    10 h-index

    38 publications

    4.6K citations

  8. University of Ferrara

    Ferrara, Italy

    10 h-index

    11 publications

    1.8K citations

1–8 of 335

Venues

  1. International Journal of COPD

    13 publications · 399 citations

    15

    h-index

  2. Respiratory Medicine

    12 publications · 616 citations

    11

    h-index

  3. PubMed

    Repository · 7 publications · 158 citations

    7

    h-index

  4. Respiratory Research

    RR · 7 publications · 197 citations

    7

    h-index

  5. CHEST Journal

    7 publications · 574 citations

    7

    h-index

1–5